MUNICH, October 19, 2025--(BUSINESS WIRE)--Tubulis today announced positive early clinical data from its NAPISTAR1-01 Phase I/IIa study (NCT06303505) in a late-breaking oral presentation at the ...

"The interim results demonstrated a highly differentiated clinical profile for TUB-040 in the ADC field, with anti-tumor activity beginning at low doses with a broad therapeutic window that could ...

The course offers market opportunities in navigating the EU Clinical Trial Regulation, optimizing product registration pathways, and streamlining submission processes. It provides competitive insights ...

The MarketWatch News Department was not involved in the creation of this content. -- TUB-040 demonstrated robust clinical activity with a favorable safety profile and excellent tolerability in ...

Rachel Reeves was handed a £3billion boost yesterday when it was revealed that borrowing figures had been overstated. The Office for National Statistics (ONS) said ...

Days after Colorado coach Deion Sanders said he believes his issues with blood clots have returned, Sanders will undergo a medical procedure but does not expect to miss practice time, he told ...

One cybersecurity expert says the stolen data might be available not just on the dark web, but also on the clear web. Hackers have leaked the personal information of up to 5.7 million Qantas customers ...